血造干细胞基因治疗中的长期血统承诺
Andrea Calabria1, Giulio Spinozzi2, Daniela Cesana2
1San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy. calabria.andrea@hsr.it.
Nature
|October 23, 2024
概括
使用造血干细胞 (HSC) 的基因治疗可以恢复血细胞功能. 然而,遗传性疾病和年龄影响高血细胞,使其适应并支持特定的血细胞类型.
科学领域:
- * 血液学
- * 基因治疗
- * 干细胞生物学
背景情况:
- * 造血干细胞基因疗法 (HSC-GT) 有可能终身纠正遗传性血液疾病.
- 遗传性疾病,细胞应激和衰老对HSC功能和血液细胞发育的长期影响尚不完全理解.
- 了解这些因素对于优化基因治疗结果至关重要.
研究的目的:
- * 在接受透视性HSC-GT的患者中研究长期的造血复制和血统特征.
- * 分析潜在的遗传疾病,患者年龄和疾病严重程度对HSC行为和克隆输出的影响.
- * 为了确定HSC对病理状况的适应机制.
主要方法:
- * 对53名因甲色白血病,威斯科特- 阿尔德里奇综合征和β- thalassemia治疗的患者的造血复合的分析.
- *长度跟踪长达8年,使用载体集成站点来追踪克隆身份和扩张.
- * 评估HSC数量,多个血统潜力,血统特定的承诺和体质突变率.
主要成果:
- * 长期的造血复制得到了大量活跃的HSC (770至35,000).
- * 50% 的移植克隆在所有研究条件下都表现出多个血统的潜力.
- * 一个克隆子组表现出疾病特异性血统偏好 (MLD的髓状,WAS的淋巴状,β- thalassemia的红细胞),特别是在成年患者中.
- * HSC行为,包括克隆性活动,血统输出和突变率,受到潜在疾病和患者年龄的显著影响.
结论:
- 在基因治疗和复制过程中,造血干细胞表现出适应性反应.
- * HSC-GT的长期成功取决于遗传性疾病,患者年龄和治疗干预措施之间的相互作用.
- 在HSC克隆中观察到的疾病特异性血统承诺突显了遗传缺陷和干细胞行为之间的复杂相互作用.
相关概念视频
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:21Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
01:22Bone Marrow Sampling and Transplants
304
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
304